VISTAPHARM LLC
GenericsVISTAPHARM LLC is a generic drug manufacturer focused on Oncology, Gastroenterology, Neurology.
VISTAPHARM LLC's Key Drugs
VISTAPHARM LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
VISTAPHARM LLC's Recent FDA Approvals
New NDA/BLA approvals for VISTAPHARM LLC over the last two years — novel drugs only, excluding generics and label supplements.
VISTAPHARM LLC's Therapeutic Areas
VISTAPHARM LLC's approved drugs and pipeline span 3 therapeutic areas, led by Oncology and Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
VISTAPHARM LLC's Top Competitors
VISTAPHARM LLC's closest competitors by therapeutic-area and drug-target overlap include Bristol-Myers Squibb, Pfizer, and EMD SERONO. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
VISTAPHARM LLC Pipeline Snapshot
Active clinical trials for VISTAPHARM LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1992-09-30
- Latest
- 2026-06-18
- Applications
- 20